ephrin-a5 has been researched along with Liver Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, TC; Ho, JY; Ng, KF; Wang, TH; Yeh, CT | 1 |
Chen, TC; Liang, KH; Ng, KF; Wang, TH; Wang, YL; Yeh, CT; Yeh, TS | 1 |
2 other study(ies) available for ephrin-a5 and Liver Neoplasms
Article | Year |
---|---|
OncomiR miR-96 and miR-182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Ephrin-A5; Gene Expression Regulation, Neoplastic; Humans; Liver; Liver Neoplasms; MicroRNAs; Neoplasm Invasiveness | 2016 |
Peritumoral small ephrinA5 isoform level predicts the postoperative survival in hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease-Free Survival; Down-Regulation; Ephrin-A5; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Linear Models; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Protein Isoforms; Proteolysis; Proto-Oncogene Proteins c-cbl; Receptors, Eph Family; Tumor Microenvironment; Tumor Suppressor Proteins | 2012 |